欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Metabolic Enzyme  /  IDH  /  艾伏尼布

CAS No.: 1448347-49-6

艾伏尼布 Catalog No. CSN17323

Synonyms: AG-120;Invosidenib;RG-120

AG-120 is a first-in-class mutant IDH1 inhibitor.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT03013998Previously Untreated Acute Mye... more >>loid Leukemia Collapse <<Phase 1 Phase 2RecruitingDecember 2021United States, Arizona ... more >> Mayo Clinic Arizona Recruiting Phoenix, Arizona, United States, 85054 Principal Investigator: Lisa Sproat, MD          United States, California UCLA Ronald Reagan Medical Center Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Gary Schiller, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Principal Investigator: Gabriel Mannis, MD          United States, Colorado University of Colorado Recruiting Denver, Colorado, United States, 80203 Principal Investigator: Dan Pollyea, MD          United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Principal Investigator: James Foran, MD          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30308 Principal Investigator: William Blum, MD          United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Principal Investigator: Wendy Stock, MD          United States, Maryland University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Principal Investigator: Maria Baer, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Principal Investigator: Eytan M Stein, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: John C Byrd, MD          Principal Investigator: Alice Mims, MD          Principal Investigator: Alison R Walker, MD, MPH          United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Principal Investigator: Uma Borate, MD          United States, Texas University of Texas Southwestern Recruiting Dallas, Texas, United States, 75390 Principal Investigator: Prapti Patel, MD          United States, Utah Huntsman Cancer Institute, University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Principal Investigator: Michael Deininger, MD, PhD Collapse <<
    NCT03564821IDH1 Mutation Myeloid Neoplasm... more >>s Collapse <<Phase 1Not yet recruitingJuly 31, 2024United States, Massachusetts ... more >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02214 Contact: Amir T Fathi, MD    617-724-4000    afathi@partners.org    Principal Investigator: Amir T Fathi, MD Collapse <<
    NCT02831972HealthyPhase 1Completed-United States, Arizona ... more >> Tempe, Arizona, United States, 85283 Collapse <<
  • 更多

实验方案

技术信息

CAS号 1448347-49-6 储存条件
分子式 C28H22ClF3N6O3 运输 蓝冰
分子量 582.96 别名 AG-120;Invosidenib;RG-120;Tibsovo
溶解度
DMSO100.0 mg/mL (171.5 mM)
WaterInsoluble
Ethanol99.0 mg/mL (169.8 mM)
动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们